(KOF) Coca-Cola Femsa SAB de CV - Overview
Stock: Soft Drinks, Water, Juice, Beer, Energy Drink
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.34% |
| Yield on Cost 5y | 10.79% |
| Yield CAGR 5y | 11.28% |
| Payout Consistency | 88.1% |
| Payout Ratio | 93.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.3% |
| Relative Tail Risk | -1.17% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.50 |
| Alpha | 41.69 |
| Character TTM | |
|---|---|
| Beta | 0.245 |
| Beta Downside | -0.011 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.48% |
| CAGR/Max DD | 0.87 |
Description: KOF Coca-Cola Femsa SAB de CV December 19, 2025
Coca-Cola FEMSA (KOF) is the largest independent Coca-Cola bottler in the world, operating across nine Latin-American countries (Mexico, Central America, Brazil, Argentina, Uruguay, etc.). It manufactures, markets and distributes a broad portfolio that includes carbonated soft drinks, water, tea, sports and energy drinks, juices, coffee, dairy-alternatives, as well as third-party brands such as Heineken beer, Campari spirits, Perfetti confectionery and Monster energy.
Key operating metrics (2023): net sales of roughly $13.5 billion, an adjusted EBITDA margin near 16 % and a free-cash-flow conversion of about 70 % of EBITDA. The company’s growth is driven by a shift toward higher-margin non-carbonated beverages (which now represent ~30 % of sales) and by price-pass-through mechanisms that offset inflationary pressures in its primary markets.
Macro drivers include Mexico’s GDP growth (averaging ~2 % YoY), rising disposable income in Brazil and Argentina, and the broader soft-drink sector’s transition toward healthier, low-sugar formats-trends that underpin volume resilience and allow KOF to leverage its extensive distribution network.
For a deeper, data-driven analysis of KOF’s valuation and risk profile, the ValueRay platform provides a granular view of the metrics discussed.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 23.63b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -4.84 > 1.0 |
| NWC/Revenue: 2.33% < 20% (prev 0.19%; Δ 2.14% < -1%) |
| CFO/TA 0.04 > 3% & CFO 12.20b > Net Income 23.63b |
| Net Debt (45.62b) to EBITDA (41.48b): 1.10 < 3 |
| Current Ratio: 1.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (210.1m) vs 12m ago 0.0% < -2% |
| Gross Margin: 45.76% > 18% (prev 0.46%; Δ 4531 % > 0.5%) |
| Asset Turnover: 175.8% > 50% (prev 1697 %; Δ -1521 % > 0%) |
| Interest Coverage Ratio: 3.86 > 6 (EBITDA TTM 41.48b / Interest Expense TTM 6.12b) |
Altman Z'' 2.82
| A: 0.02 (Total Current Assets 77.13b - Total Current Liabilities 70.34b) / Total Assets 315.27b |
| B: 0.34 (Retained Earnings 108.27b / Total Assets 315.27b) |
| C: 0.14 (EBIT TTM 23.62b / Avg Total Assets 165.49b) |
| D: 0.57 (Book Value of Equity 95.06b / Total Liabilities 166.52b) |
| Altman-Z'' Score: 2.82 = A |
Beneish M 1.00
| DSRI: 23.22 (Receivables 28.32b/1.12b, Revenue 290.88b/266.57b) |
| GMI: 1.00 (GM 45.76% / 45.73%) |
| AQI: 0.95 (AQ_t 0.41 / AQ_t-1 0.43) |
| SGI: 1.09 (Revenue 290.88b / 266.57b) |
| TATA: 0.04 (NI 23.63b - CFO 12.20b) / TA 315.27b) |
| Beneish M-Score: 15.34 (Cap -4..+1) = D |
What is the price of KOF shares?
Over the past week, the price has changed by +5.40%, over one month by +15.48%, over three months by +26.61% and over the past year by +47.13%.
Is KOF a buy, sell or hold?
- StrongBuy: 6
- Buy: 6
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KOF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 103.8 | -6.4% |
| Analysts Target Price | 103.8 | -6.4% |
| ValueRay Target Price | 135.5 | 22.2% |
KOF Fundamental Data Overview February 04, 2026
P/E Trailing = 40.9416
P/E Forward = 117.6471
P/S = 0.0762
P/B = 2.6626
P/EG = 33.5829
Revenue TTM = 290.88b MXN
EBIT TTM = 23.62b MXN
EBITDA TTM = 41.48b MXN
Long Term Debt = 74.02b MXN (from longTermDebt, last quarter)
Short Term Debt = 4.49b MXN (from shortTermDebt, last quarter)
Debt = 80.52b MXN (from shortLongTermDebtTotal, last quarter)
Net Debt = 45.62b MXN (from netDebt column, last quarter)
Enterprise Value = 434.09b MXN (381.46b + Debt 80.52b - CCE 27.88b)
Interest Coverage Ratio = 3.86 (Ebit TTM 23.62b / Interest Expense TTM 6.12b)
EV/FCF = 72.09x (Enterprise Value 434.09b / FCF TTM 6.02b)
FCF Yield = 1.39% (FCF TTM 6.02b / Enterprise Value 434.09b)
FCF Margin = 2.07% (FCF TTM 6.02b / Revenue TTM 290.88b)
Net Margin = 8.12% (Net Income TTM 23.63b / Revenue TTM 290.88b)
Gross Margin = 45.76% ((Revenue TTM 290.88b - Cost of Revenue TTM 157.76b) / Revenue TTM)
Gross Margin QoQ = 45.06% (prev 45.31%)
Tobins Q-Ratio = 1.38 (Enterprise Value 434.09b / Total Assets 315.27b)
Interest Expense / Debt = 2.41% (Interest Expense 1.94b / Debt 80.52b)
Taxrate = 30.54% (2.70b / 8.84b)
NOPAT = 16.41b (EBIT 23.62b * (1 - 30.54%))
Current Ratio = 1.10 (Total Current Assets 77.13b / Total Current Liabilities 70.34b)
Debt / Equity = 0.57 (Debt 80.52b / totalStockholderEquity, last quarter 141.93b)
Debt / EBITDA = 1.10 (Net Debt 45.62b / EBITDA 41.48b)
Debt / FCF = 7.58 (Net Debt 45.62b / FCF TTM 6.02b)
Total Stockholder Equity = 107.28b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.28% (Net Income 23.63b / Total Assets 315.27b)
RoE = 22.03% (Net Income TTM 23.63b / Total Stockholder Equity 107.28b)
RoCE = 13.03% (EBIT 23.62b / Capital Employed (Equity 107.28b + L.T.Debt 74.02b))
RoIC = 7.44% (NOPAT 16.41b / Invested Capital 220.53b)
WACC = 5.92% (E(381.46b)/V(461.97b) * Re(6.82%) + D(80.52b)/V(461.97b) * Rd(2.41%) * (1-Tc(0.31)))
Discount Rate = 6.82% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.00%
[DCF Debug] Terminal Value 80.69% ; FCFF base≈4.04b ; Y1≈2.65b ; Y5≈1.21b
Fair Price DCF = N/A (negative equity: EV 38.25b - Net Debt 45.62b = -7.38b; debt exceeds intrinsic value)
EPS Correlation: 53.57 | EPS CAGR: 3.70% | SUE: -1.95 | # QB: 0
Revenue Correlation: 53.96 | Revenue CAGR: 8.32% | SUE: 0.73 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.36 | Chg30d=-0.020 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=6.96 | Chg30d=-0.018 | Revisions Net=-1 | Growth EPS=+15.1% | Growth Revenue=+5.6%